SCA
IBB icon

Strategic Capital Alternatives’s iShares Biotechnology ETF IBB Stock Holding History

Strategic Capital Alternatives’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$93K Sell
921
-231
-20% -$27.7K 0.02% 197
2015
Q2 		$136K Sell
1,152
-45
-4% -$5.39K 0.03% 214
2015
Q1 		$137K Buy
+1,197
New +$132K 0.03% 186
2014
Q4 		– Sell
-357
Closed -$33K – 199
2014
Q3 		$33K Buy
+357
New +$31.3K 0.01% 278

Other funds holding IBB

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Strategic Capital Alternatives's IBB Position: Q3 2015 in Review

Strategic Capital Alternatives reduced its iShares Biotechnology ETF (IBB) stake by 20% in Q3 2015, selling an estimated $27.7K and leaving 921 shares worth $93K. The position accounts for 0.02% of the portfolio, ranked #197.

Strategic Capital Alternatives first reported a position in IBB in Q3 2014 and has held it in 4 quarters since. The position peaked at $137K in Q1 2015. 415 funds tracked by Wall St. Rank hold IBB as of Q3 2015.

  • Strategic Capital Alternatives held 921 shares of iShares Biotechnology ETF worth $93K as of Q3 2015.
  • Strategic Capital Alternatives sold 231 iShares Biotechnology ETF shares in Q3 2015, an estimated $27.7K.
  • iShares Biotechnology ETF made up 0.02% of Strategic Capital Alternatives's portfolio in Q3 2015, its #197 holding.
  • Strategic Capital Alternatives first reported a position in iShares Biotechnology ETF in Q3 2014 and has held it in 4 quarters since.
  • Strategic Capital Alternatives's iShares Biotechnology ETF position peaked at $137K in Q1 2015.
  • 415 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.